Butyrate Therapy in Hispanic Children With Ulcerative Colitis
Who is this study for? Patients with Ulcerative Colitis
What treatments are being studied? Butyrate
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Maximum Age: 21
Healthy Volunteers: f
View:
• 7-21 years, mild to moderate ulcerative colitis
Locations
United States
California
Children's Hospital Los Angeles
RECRUITING
Los Angeles
Contact Information
Primary
Sonia Michail, MD
sonia.michail@hotmail.com
3233611353
Time Frame
Start Date: 2022-06-29
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 10
Treatments
Experimental: open label intervention arm
Butyrate enemas will be administered once daily for twelve weeks.
Related Therapeutic Areas
Sponsors
Leads: Children's Hospital Los Angeles